Microbot Financial Statements From 2010 to 2025

MBOT Stock  USD 1.71  0.05  3.01%   
Microbot Medical financial statements provide useful quarterly and yearly information to potential Microbot Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Microbot Medical financial statements helps investors assess Microbot Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Microbot Medical's valuation are summarized below:
Market Capitalization
57.7 M
Earnings Share
(0.79)
There are currently one hundred twenty fundamental ratios for Microbot Medical that can be evaluated and compared over time across peers in the industry. All traders should check Microbot Medical's last-minute fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 28.5 M in 2025, whereas Market Cap is likely to drop slightly above 18.3 M in 2025.

Microbot Medical Total Revenue

0.0

Check Microbot Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbot Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 90.6 K, Interest Expense of 158.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 302, Dividend Yield of 58.41 or PTB Ratio of 4.49. Microbot financial statements analysis is a perfect complement when working with Microbot Medical Valuation or Volatility modules.
  
Check out the analysis of Microbot Medical Correlation against competitors.
For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

Microbot Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets7.1 M7.5 M18.8 M
Slightly volatile
Short and Long Term Debt Total197.5 K207.9 K2.9 M
Slightly volatile
Other Current Liabilities2.6 M3.7 MM
Slightly volatile
Total Current Liabilities4.8 M4.4 M4.5 M
Slightly volatile
Property Plant And Equipment Net347.1 K365.4 K1.6 M
Slightly volatile
Accounts Payable489.2 K321.3 K368.4 K
Slightly volatile
Cash2.7 M2.8 M12.2 M
Slightly volatile
Non Current Assets Total347.1 K365.4 K2.7 M
Slightly volatile
Cash And Short Term InvestmentsM7.3 M15 M
Slightly volatile
Net Receivables1.6 M1.5 M447.4 K
Slightly volatile
Common Stock Shares Outstanding12.3 M11.7 M4.1 M
Slightly volatile
Liabilities And Stockholders Equity7.1 M7.5 M18.8 M
Slightly volatile
Non Current Liabilities Total34.2 K36 K4.3 M
Slightly volatile
Other Current Assets207.8 K218.7 K959.1 K
Very volatile
Other Stockholder Equity101.3 M96.5 M166.3 M
Slightly volatile
Total Liabilities3.3 M3.4 M8.6 M
Slightly volatile
Total Current Assets6.8 M7.1 M16.1 M
Slightly volatile
Short Term Debt208.7 K219.7 K790.5 K
Slightly volatile
Property Plant And Equipment Gross768.6 K809.1 K2.3 M
Slightly volatile
Common Stock Total Equity61.5664.8322.6 K
Slightly volatile
Common Stock100.9 K106.2 K356.9 K
Slightly volatile
Current Deferred Revenue1.4 M927.9 K2.4 M
Slightly volatile
Long Term Debt Total83 K87.4 K1.9 M
Slightly volatile
Capital Surpluse58.6 M61.7 M180.1 M
Slightly volatile
Deferred Long Term Liabilities6.8 K7.2 K513.6 K
Slightly volatile
Non Current Liabilities Other535.2 K563.4 K2.4 M
Slightly volatile
Property Plant Equipment1.2 M650.7 K1.4 M
Slightly volatile
Capital Lease Obligations432.7 K265.6 K412.2 K
Slightly volatile
Other Liabilities6.8 K7.2 K1.1 M
Slightly volatile
Short and Long Term Debt65 K68.4 K1.5 M
Slightly volatile
Warrants400 K450 K490.6 K
Slightly volatile
Net Invested Capital3.8 M4.1 M10.7 M
Very volatile
Net Working Capital3.5 M3.7 M10.7 M
Pretty Stable
Capital Stock81.6 K135.7 K56.9 K
Slightly volatile

Microbot Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization90.6 K95.4 K424.9 K
Slightly volatile
Other Operating Expenses14.3 M8.9 M15.8 M
Slightly volatile
Total Operating Expenses18.8 M11.3 M15.9 M
Slightly volatile
Research Development9.5 M5.1 M10.2 M
Slightly volatile
Selling General Administrative3.5 M3.7 M587.8 M
Pretty Stable
Selling And Marketing Expenses182192849 M
Slightly volatile
Non Recurring524 K589.5 K642.7 K
Slightly volatile
Interest Income256 K243.8 K68.3 K
Slightly volatile
Reconciled Depreciation80 K119.6 K53.5 K
Slightly volatile

Microbot Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow2.8 M2.9 M12.1 M
Pretty Stable
Depreciation90.6 K95.4 K424.9 K
Slightly volatile
Capital Expenditures28.2 K29.7 K535.4 K
Slightly volatile
End Period Cash Flow2.2 M2.3 M12.6 M
Slightly volatile
Stock Based Compensation1.2 M1.3 M79.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio302383299
Slightly volatile
Dividend Yield58.4161.4974.6214
Slightly volatile
Days Sales Outstanding77.3581.4296.5469
Slightly volatile
Average Payables708.7 K1.1 M856.4 K
Pretty Stable
Stock Based Compensation To Revenue39.6341.72122
Slightly volatile
Capex To Depreciation0.340.361.5102
Pretty Stable
Payables Turnover0.320.341.0215
Slightly volatile
Sales General And Administrative To Revenue75.4 K71.8 K54.1 K
Slightly volatile
Research And Ddevelopement To Revenue219209162
Slightly volatile
Capex To Revenue8.518.116.5111
Slightly volatile
Cash Per Share0.680.722.7 K
Slightly volatile
Days Payables Outstanding8371.1 K1.5 K
Very volatile
Income Quality0.950.910.7864
Pretty Stable
Intangibles To Total Assets0.00190.0020.0284
Slightly volatile
Net Debt To EBITDA0.180.191.0721
Pretty Stable
Current Ratio1.791.885.9361
Very volatile
Receivables Turnover4.414.643.8295
Slightly volatile
Capex Per Share0.00350.0037128
Slightly volatile
Average Receivables332.5 K454.8 K446.9 K
Slightly volatile
Revenue Per Share1.751.8499.4453
Slightly volatile
Interest Debt Per Share0.02470.026268
Slightly volatile
Debt To Assets0.03030.03190.1039
Slightly volatile
Graham Number14.4516.2517.7211
Slightly volatile
Days Of Payables Outstanding8371.1 K1.5 K
Very volatile
Long Term Debt To Capitalization0.03670.03860.4032
Pretty Stable
Total Debt To Capitalization0.04170.04390.1722
Slightly volatile
Quick Ratio1.81.895.9598
Very volatile
Cash Ratio0.560.594.7065
Pretty Stable
Days Of Sales Outstanding77.3581.4296.5469
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.221.151.0589
Very volatile
Fixed Asset Turnover0.02450.02580.1588
Slightly volatile
Debt Ratio0.03030.03190.1039
Slightly volatile
Price Sales Ratio302383299
Slightly volatile
Asset Turnover0.0060.00630.0153
Slightly volatile

Microbot Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap18.3 M19.2 M33.8 M
Slightly volatile

Microbot Fundamental Market Drivers

Cash And Short Term Investments6.4 M

Microbot Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
15th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Microbot Medical Financial Statements

Microbot Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Microbot Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Microbot Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Microbot Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue927.9 K1.4 M
Cost Of Revenue95.4 K90.6 K
Stock Based Compensation To Revenue 41.72  39.63 
Sales General And Administrative To Revenue71.8 K75.4 K
Research And Ddevelopement To Revenue 208.55  218.97 
Capex To Revenue 8.11  8.51 
Revenue Per Share 1.84  1.75 
Ebit Per Revenue(360.92)(342.88)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.